Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

XBIT XBiotech Inc

0.00 (0.00%)
Pre Market
Last Updated: 07:00:07
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 7.11
Ask Price 9.85
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
XBiotech Inc XBIT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 7.91 07:00:07
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 3.05 - 9.96
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 7.91 USD

XBiotech Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
240.76M 30.44M - 4.01M -32.9M -1.08 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

XBiotech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No XBIT Message Board. Create One! See More Posts on XBIT Message Board See More Message Board Posts

Historical XBIT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week9.379.597.558.6481,287-1.46-15.58%
1 Month7.259.966.998.70104,4820.669.10%
3 Months4.209.964.1457.4271,4963.7188.33%
6 Months3.959.963.516.6343,9683.96100.25%
1 Year3.529.963.055.7049,4164.39124.72%
3 Years17.5018.463.008.6361,376-9.59-54.80%
5 Years9.1233.203.0014.35137,808-1.21-13.27%

XBiotech Description

XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Your Recent History

Delayed Upgrade Clock